Efficacy and safety of ustekinumab in the treatment of moderate to severe plaque psoriasis in Singapore

Introduction: Ustekinumab is a human monoclonal antibody that binds to the p40 subunit of both interleukin (IL)-12 and IL-23, and it is approved for the treatment of moderate to severe plaque psoriasis. In this study, we assessed the efficacy and safety of patients receiving ustekinumab for psoriasi...

Full description

Bibliographic Details

Published in:	Singapore medical journal Vol. 64; no. 7; pp. 434 - 438
Main Authors:	Chan, Wai, Wong, Yisheng, Oon, Hazel, Theng, Colin, Chong, Wei-Sheng
Format:	Journal Article
Language:	English
Published:	India Wolters Kluwer India Pvt. Ltd 01-07-2023 Medknow Publications and Media Pvt. Ltd Wolters Kluwer - Medknow
Subjects:	Drug therapy Interleukins Medical research Medicine, Experimental Monoclonal antibodies Original Psoriasis Asia China Singapore Biologic psoriasis ustekinumab
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!